|
BN91137 |
Gemtuzumab |
2924764-21-4 |
|
|
VIEW DETAILS > |
|
BO20475 |
GW297361 |
388627-21-2 |
|
|
VIEW DETAILS > |
|
BO20504 |
GV-150013X |
151386-96-8 |
|
|
VIEW DETAILS > |
|
BO20507 |
Glucocorticoid receptor agonist-3 |
2842165-73-3 |
C36H40FNO7 |
617.7037 |
VIEW DETAILS > |
|
BO20264 |
Glembatumumab vedotin |
1182215-65-1 |
|
|
VIEW DETAILS > |
|
BO20270 |
Glycopyrronium tosylate |
1624259-25-1 |
|
|
VIEW DETAILS > |
|
BO21662 |
Glucocorticoid receptor agonist-4 |
2842165-72-2 |
C36H40FNO7 |
617.7037 |
VIEW DETAILS > |
|
BO21910 |
GPAT-IN-1 |
1204347-51-2 |
C21H26ClNO4S |
423.9534 |
VIEW DETAILS > |
|
BO23794 |
Glu-urea-Lys |
1025796-69-3 |
|
|
VIEW DETAILS > |
|
BJ21821 |
Glycyl-L-aspartic acid hydrate |
1366384-20-4 |
C6H12N2O6 |
208.1693 |
VIEW DETAILS > |